Latest Insider Transactions at Merck & Co., Inc. (MRK)
This section provides a real-time view of insider transactions for Merck & Co., Inc. (MRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Merck & Co., Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Merck & Co., Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
803
+1.74%
|
$93,951
$117.89 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Open market or private sale
|
Direct |
7,509
-40.44%
|
$871,044
$116.82 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,035
+24.53%
|
$337,960
$56.04 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-1.56%
|
$22,770
$115.47 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+4.34%
|
$66,355
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.71%
|
$36,685
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
930
+2.03%
|
$106,950
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-2.5%
|
$60,260
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,062
+4.81%
|
$122,130
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.33%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+2.63%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.16%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.21%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-5.05%
|
$25,415
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
643
+12.81%
|
$73,945
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.25%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.38%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
75,436
-32.81%
|
$8,750,576
$116.03 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
75,436
+24.7%
|
$4,224,416
$56.04 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
66,163
-29.98%
|
$7,608,745
$115.0 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
66,163
+23.07%
|
$4,102,106
$62.07 P/Share
|
|
Apr 28
2023
|
Robert M Davis Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
143,329
-34.53%
|
$16,339,506
$114.93 P/Share
|
|
Apr 28
2023
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
143,329
+25.66%
|
$8,026,424
$56.04 P/Share
|
|
Apr 26
2023
|
Joseph Romanelli President, Human Health Int?l |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$339
$113.68 P/Share
|
|
Apr 13
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
134,055
-74.68%
|
$15,416,325
$115.06 P/Share
|
|
Apr 13
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
134,055
+41.52%
|
$7,909,245
$59.06 P/Share
|
|
Mar 24
2023
|
Joseph Romanelli President, Human Health Int?l |
SELL
Open market or private sale
|
Direct |
35
-0.17%
|
$3,640
$104.65 P/Share
|
|
Mar 20
2023
|
Joseph Romanelli President, Human Health Int?l |
BUY
Open market or private purchase
|
Direct |
136
+0.65%
|
$14,280
$105.47 P/Share
|
|
Feb 21
2023
|
Joseph Romanelli President, Human Health Int?l |
BUY
Open market or private purchase
|
Direct |
11
+0.05%
|
$1,199
$109.2 P/Share
|
|
Feb 15
2023
|
Joseph Romanelli President, Human Health Int?l |
SELL
Open market or private sale
|
Direct |
5,000
-19.78%
|
$540,000
$108.22 P/Share
|
|
Feb 13
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,815
-5.2%
|
$197,835
$109.1 P/Share
|
|
Feb 10
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-3.3%
|
$43,778
$106.72 P/Share
|
|
Feb 10
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,205
+8.79%
|
$127,730
$106.72 P/Share
|
|
Feb 09
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.53%
|
$535,000
$107.0 P/Share
|
|
Feb 06
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
4,436
-10.01%
|
$461,344
$104.25 P/Share
|
|
Feb 03
2023
|
Jennifer Zachary EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
75,436
-58.32%
|
$7,769,908
$103.17 P/Share
|
|
Feb 03
2023
|
Jennifer Zachary EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
75,436
+36.84%
|
$4,224,416
$56.04 P/Share
|
|
Jan 23
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,745
+13.68%
|
$190,205
$109.88 P/Share
|
|
Jan 23
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Grant, award, or other acquisition
|
Direct |
2,091
+10.0%
|
$227,919
$109.88 P/Share
|
|
Jan 23
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,846
+6.08%
|
$310,214
$109.88 P/Share
|
|
Jan 23
2023
|
Steven Mizell EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,192
+21.57%
|
$1,328,928
$109.88 P/Share
|
|
Jan 23
2023
|
Dean Y Li Executive VP & President, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
3,275
+14.11%
|
$356,975
$109.88 P/Share
|
|
Jan 23
2023
|
Jennifer Zachary EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,631
+22.47%
|
$1,703,779
$109.88 P/Share
|
|
Jan 23
2023
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+8.18%
|
$2,640,416
$109.88 P/Share
|
|
Jan 23
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
15,628
+9.24%
|
$1,703,452
$109.88 P/Share
|
|
Jan 23
2023
|
Caroline Litchfield EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,656
+8.09%
|
$289,504
$109.88 P/Share
|
|
Jan 23
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,651
+12.84%
|
$288,959
$109.88 P/Share
|
|
Jan 23
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
17,495
+27.13%
|
$1,906,955
$109.88 P/Share
|
|
Jan 09
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
83,994
-20.61%
|
$9,407,328
$112.67 P/Share
|
|
Jan 09
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
83,994
+42.53%
|
$4,451,682
$53.06 P/Share
|